Ciraparantag Uses, Dosage, Side Effects and more
Ciraparantag is under investigation in clinical trial NCT01826266 (Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban).
| Trade Name | Ciraparantag |
| Generic | Ciraparantag |
| Ciraparantag Other Names | Ciraparantag, Ciraparantagum |
| Type | |
| Formula | C22H48N12O2 |
| Weight | Average: 512.708 Monoisotopic: 512.402318834 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
